Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of DexCom, Inc. (DXCM) are currently slipping over 10% despite the medical device company's third-quarter results beating Wall Street estimates. U.S. stocks are trading down on Wednesday morning as investors are worried about the economic impact of spike in coronavirus cases lately.


RTTNews | Oct 28, 2020 10:01AM EDT

10:00 Wednesday, October 28, 2020 (RTTNews.com) - Shares of DexCom, Inc. (DXCM) are currently slipping over 10% despite the medical device company's third-quarter results beating Wall Street estimates. U.S. stocks are trading down on Wednesday morning as investors are worried about the economic impact of spike in coronavirus cases lately.

DXCM is currently trading at $340.21, up $40.42 or 10.62%, on the Nasdaq.

Tuesday, DexCom reported third-quarter profit of $72.2 million or $0.73 per share, up from $45.8 million or $0.50 per share last year. Adjusted earnings increased to $0.94 per share from $0.65 per share last year. Analysts polled by Thomson Reuters estimated earnings of $0.64 per share.

Revenues for the quarter grew 26% to $500.9 million from $396.3 million last year. Analysts had a consensus estimate of $476.75 million.

Looking forward, DexCom expects revenues of about $1.90 billion for the full year. Analysts currently estimate revenues of $1.87 billion.

On Monday, DexCom said that Rick Doubleday, the company's executive vice president and chief commercial officer, will retire at the end of 2020.

Read the original article on RTTNews ( https://www.rttnews.com/3140164/stock-alert-dexcom-slips-10.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC